Laguna Hills-based CardioPolymers, a developer of an implantable device for treating congestive heart failure, has added $1.35M to its venture funding, according to numbers from the latest PricewaterhouseCoopers/NVCA quarterly venture capital report. No details on the funding have been announced by the company. The firm has previously raised funding from Domain Associates, Morgenthaler Ventures, Johnson & Johnson Development Corporation, Triathlon Medical Ventures, Saints Capital, and Fjord Ventures. More information »